Your browser doesn't support javascript.
loading
ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.
Thompson, Paul M; Jahanshad, Neda; Ching, Christopher R K; Salminen, Lauren E; Thomopoulos, Sophia I; Bright, Joanna; Baune, Bernhard T; Bertolín, Sara; Bralten, Janita; Bruin, Willem B; Bülow, Robin; Chen, Jian; Chye, Yann; Dannlowski, Udo; de Kovel, Carolien G F; Donohoe, Gary; Eyler, Lisa T; Faraone, Stephen V; Favre, Pauline; Filippi, Courtney A; Frodl, Thomas; Garijo, Daniel; Gil, Yolanda; Grabe, Hans J; Grasby, Katrina L; Hajek, Tomas; Han, Laura K M; Hatton, Sean N; Hilbert, Kevin; Ho, Tiffany C; Holleran, Laurena; Homuth, Georg; Hosten, Norbert; Houenou, Josselin; Ivanov, Iliyan; Jia, Tianye; Kelly, Sinead; Klein, Marieke; Kwon, Jun Soo; Laansma, Max A; Leerssen, Jeanne; Lueken, Ulrike; Nunes, Abraham; Neill, Joseph O'; Opel, Nils; Piras, Fabrizio; Piras, Federica; Postema, Merel C; Pozzi, Elena; Shatokhina, Natalia.
Afiliación
  • Thompson PM; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA. pthomp@usc.edu.
  • Jahanshad N; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Ching CRK; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Salminen LE; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Thomopoulos SI; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Bright J; Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
  • Baune BT; Department of Psychiatry, University of Münster, Münster, Germany.
  • Bertolín S; Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
  • Bralten J; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Bruin WB; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.
  • Bülow R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Chen J; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Chye Y; Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Dannlowski U; Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • de Kovel CGF; Department of Computer Science and Engineering, The Ohio State University, Columbus, OH, USA.
  • Donohoe G; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia.
  • Eyler LT; Department of Psychiatry, University of Münster, Münster, Germany.
  • Faraone SV; Biometris Wageningen University and Research, Wageningen, The Netherlands.
  • Favre P; Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Filippi CA; The Center for Neuroimaging and Cognitive Genomics, School of Psychology, National University of Ireland, Galway, Ireland.
  • Frodl T; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
  • Garijo D; Desert-Pacific Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare System, San Diego, CA, USA.
  • Gil Y; Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
  • Grabe HJ; INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
  • Grasby KL; NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.
  • Hajek T; National Institute of Mental Health, National of Health, Bethesda, MD, USA.
  • Han LKM; Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Hatton SN; Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
  • Hilbert K; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Ho TC; Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.
  • Holleran L; Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.
  • Homuth G; Department of Computer Science, University of Southern California, Los Angeles, CA, USA.
  • Hosten N; Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  • Houenou J; German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
  • Ivanov I; Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Jia T; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Kelly S; National Institute of Mental Health, Klecany, Czech Republic.
  • Klein M; Department of Psychiatry, Amsterdam University Medical Centers, VU University Medical Center, GGZ inGeest, Amsterdam Neuroscience, Amsterdam, The Netherlands.
  • Kwon JS; Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA.
  • Laansma MA; Brain and Mind Centre, University of Sydney, Sydney, Australia.
  • Leerssen J; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Lueken U; Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.
  • Nunes A; Department of Psychiatry & Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
  • Neill JO; The Center for Neuroimaging and Cognitive Genomics, School of Psychology, National University of Ireland, Galway, Ireland.
  • Opel N; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
  • Piras F; Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.
  • Piras F; INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
  • Postema MC; NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.
  • Pozzi E; APHP, Mondor University Hospitals, School of Medicine, DMU Impact, Psychiatry Department, Créteil, France.
  • Shatokhina N; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Transl Psychiatry ; 10(1): 100, 2020 03 20.
Article en En | MEDLINE | ID: mdl-32198361
ABSTRACT
This review summarizes the last decade of work by the ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) Consortium, a global alliance of over 1400 scientists across 43 countries, studying the human brain in health and disease. Building on large-scale genetic studies that discovered the first robustly replicated genetic loci associated with brain metrics, ENIGMA has diversified into over 50 working groups (WGs), pooling worldwide data and expertise to answer fundamental questions in neuroscience, psychiatry, neurology, and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological conditions, other WGs study normal variation due to sex and gender differences, or development and aging; still other WGs develop methodological pipelines and tools to facilitate harmonized analyses of "big data" (i.e., genetic and epigenetic data, multimodal MRI, and electroencephalography data). These international efforts have yielded the largest neuroimaging studies to date in schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, substance use disorders, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorders, epilepsy, and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating disorders, irritability, brain injury, antisocial personality and conduct disorder, and dissociative identity disorder. Here, we summarize the first decade of ENIGMA's activities and ongoing projects, and describe the successes and challenges encountered along the way. We highlight the advantages of collaborative large-scale coordinated data analyses for testing reproducibility and robustness of findings, offering the opportunity to identify brain systems involved in clinical syndromes across diverse samples and associated genetic, environmental, demographic, cognitive, and psychosocial factors.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Transl Psychiatry Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Transl Psychiatry Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos